Delivery Order 75F40124D00029-75F40124F19002
- Not listed
- This is a firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Chickasaw Business Solutions, LLC, a tribally-owned, Small Business Administration (SBA) certified 8(a) and HUBZone small business. The award, valued at $5,692,003.84, is for logistics and transportation management support services to the FDA's Office of Supply Chain Resilience (OSCR) - Logistics and Transportation Management Branch (LTMB) program. The contract has an ultimate completion date of June...
- This firm fixed-price contract was awarded by the Food and Drug Administration (FDA) to Chickasaw Business Solutions, LLC, a tribally-owned, Small Business Administration (SBA) certified 8(a) firm, to provide Information Technology (IT) program and project management support services for the Logistics and Transportation Management Branch (LTMB) systems portfolio. The contract has a total ceiling value of $774,766.80 and a period of performance ending on June 30, 2024. Chickasaw Business...
- This is a $21,664,051.44 Firm Fixed Price definitive contract awarded by the Food and Drug Administration (FDA) to Chickasaw Business Solutions, LLC, an SBA-certified 8(a) and HUBZone small business. The purpose of the contract is to provide the FDA with the necessary materials, services, and facilities to perform work needed for the agency. The contract was awarded on a sole-source basis under the 8(a) program and has an ultimate completion date of September 29, 2027. Chickasaw Business...
- This $9,418,227.11 firm fixed price delivery order was awarded by the Department of Health and Human Services Food and Drug Administration to Chickasaw Strategic Pointe, LLC, an 8(a) and HUBZone certified small business. The contract is for the Food and Drug Administration Adverse Event Reporting System (FAERS II) program, with a completion date of June 23, 2023. Chickasaw Strategic Pointe is a tribally owned, minority-owned, and disadvantaged business enterprise that provides a range of...
- The U.S. Food and Drug Administration (FDA) awarded a $4,723,142.82 Firm Fixed Price Delivery Order contract to Chickasaw Strategic Pointe, LLC, a tribally-owned, minority-owned small business, for IT Services to operate and maintain the FDA Adverse Event Reporting System (FAERS). The contract has an ultimate completion date of March 22, 2024. Chickasaw Strategic Pointe is a participant in the SBA 8(a) Business Development Program, and this contract was not set aside for any small business...
- This is a Firm Fixed Price delivery order contract awarded by the Food and Drug Administration (FDA) to Chickasaw Strategic Pointe, LLC, a tribally-owned, minority-owned small business, for the FDA Adverse Event Reporting System (FAERS) CDER Informatics Program. The contract has a ceiling value of $9,913,785.05 and a period of performance through March 22, 2025. The contract was awarded without a set-aside designation. Chickasaw Strategic Pointe, LLC is a small business that holds multiple...
- This is a federal contract award to Chickasaw Strategic Pointe, LLC, an 8(a) and HUBZone certified small business, by the Food and Drug Administration (FDA). The contract, with a ceiling value of $7,146,582.52, is for the FDA Adverse Event Reporting System (FAERS) II program. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The contract has an ultimate completion date of April 11, 2022. Chickasaw Strategic Pointe provides IT services and support for the FAERS...
- This is a delivery order contract awarded by the Food and Drug Administration (FDA) to Chickasaw Strategic Pointe, LLC, a tribally-owned, minority-owned small business. The contract is for IT operations and maintenance (O&M) and development, modernization, and enhancement (DME) support services for the FDA's Adverse Event Reporting System (FAERS). The contract has a ceiling value of $9,463,670.92 and a period of performance ending on March 22, 2026. The contract was awarded on March 21, 2025...
- This is a delivery order awarded by the Food and Drug Administration (FDA) to Chickasaw Health Consulting, LLC, a tribally-owned, minority-owned, certified 8(a) small disadvantaged business, to continue supporting the Center for Devices and Radiological Health (CDRH) Careers Rotation and Recognition Programs. The $1,160,920.58 firm fixed price delivery order is part of the FDA Human Resource Support Services 2017-2022 IDIQ contract. The work will be performed in Silver Spring, Maryland....
- The Food and Drug Administration awarded a delivery order valued at $5.9 million to Chickasaw Strategic Pointe, LLC on March 23, 2026, for information technology operations and maintenance, development, enhancement, and management support services for the FDA's Adverse Event Reporting System (FAERS) II. The work will be performed in Silver Spring, Maryland, with an ultimate completion date of December 2, 2026. The contract utilizes a labor-hour pricing model and carries no set-aside designation....
- 75F40124D00029Indefinite Delivery Contract
- 75F40124D00029-75F40124F19002Delivery Order
This is a firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Chickasaw Business Solutions, LLC, a tribally-owned, Small Business Administration (SBA) certified 8(a) and HUBZone small business. The $2,427,819.86 contract is for mail systems and shipping services support within the FDA's Logistics and Transportation Management Branch. The award has an ultimate completion date of September 29, 2029. Chickasaw Business Solutions is an experienced federal contractor, holding several significant Indefinite Delivery Vehicle (IDV) contracts with agencies like the Department of Health and Human Services, U.S. Department of Agriculture, and National Park Service, which have been used to issue numerous task orders across various service areas. This specific contract was not set aside.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Other Administrative Action | $406.9k | 9/11/25 | |
| P00001 | Exercise an Option | $349.8k | 9/4/25 | |
| Not listed | Not listed | $349.9k | 9/9/24 |